ORBITEX LIFE SCIENCE & BIOTECHNOLOGY FUND INC
N-2/A, EX-99.2(G), 2000-09-29
Previous: ORBITEX LIFE SCIENCE & BIOTECHNOLOGY FUND INC, N-2/A, 2000-09-29
Next: ORBITEX LIFE SCIENCE & BIOTECHNOLOGY FUND INC, N-2/A, EX-99.2(H), 2000-09-29





                ORBITEX LIFE SCIENCES & BIOTECHNOLOGY FUND, INC.
                          INVESTMENT ADVISORY AGREEMENT


     AGREEMENT,  made as of the 29th day of June,  2000 by and  between  Orbitex
Life Sciences & Biotechnology  Fund, Inc., a Maryland  corporation (the "Fund"),
and Orbitex Management, Inc., a New York corporation (the "Adviser").

                                   WITNESSETH:

     WHEREAS, the Fund intends to engage in business as a closed-end  investment
company and is registered as such under the  Investment  Company Act of 1940, as
amended (the "Act");

     WHEREAS, the Fund is authorized to issue shares of the Fund;

     WHEREAS,  the Adviser is  registered  as an  investment  adviser  under the
Investment Advisers Act of 1940; and

     WHEREAS,  the Fund  desires  to retain  the  Adviser  to render  investment
advisory and administrative services to the Fund with respect to the Fund in the
manner and on the terms and conditions hereinafter set forth;

     NOW, THEREFORE, the parties hereto agree as follows:

1. Services of the Adviser.

     1.1 Investment  Advisory Services.  The Adviser shall act as the investment
adviser to the Fund and, as such, shall (i) obtain and evaluate such information
relating to the economy, industries, business, securities markets and securities
as  it  may  deem  necessary  or  useful  in  discharging  its  responsibilities
hereunder,  (ii) formulate a continuing program for the investment of the assets
of the Fund in a manner consistent with its investment  objective,  policies and
restrictions,  and (iii) determine from time to time securities to be purchased,
sold, retained or lent by the Fund, and implement those decisions, including the
selection of entities with or through which such  purchases,  sales or loans are
to be effected;  provided,  that the Adviser  will place orders  pursuant to its
investment  determinations  either  directly with the issuer or with a broker or
dealer,  and if with a broker or  dealer,  (a) will  attempt  to obtain the best
price and execution of its orders,  and (b) may  nevertheless  in its discretion
purchase  and sell  portfolio  securities  from and to brokers  who  provide the
Adviser  with  research,  analysis,  advice and  similar  services  and pay such
brokers  in return a higher  commission  or spread  than may be charged by other
brokers.

     The Fund  hereby  authorizes  any  entity  or  person  associated  with the
Adviser,  which is a member of a  national  securities  exchange,  to effect any
transaction  on the  exchange  for the account of the Fund which is permitted by
Section  11(a)  of the  Securities  Exchange  Act of  1934  and  Rule  11a2-2(T)
thereunder,  and the Fund hereby consents to the retention of  compensation  for
such transactions in accordance with Rule 11a2-2(T)(a)(iv).

     The  Adviser  shall  carry  out  its  duties  with  respect  to the  Fund's
investments in accordance  with  applicable  law and the  investment  objective,
policies and  restrictions set forth in the Fund's  then-current  Prospectus and
Statement of Additional Information,  and subject to such further limitations as
the Fund may from time to time impose by written notice to the Adviser.

     1.2 Administrative  Services.  The Adviser shall manage the Fund's business
and  affairs  and  shall   provide  such   services   required   for   effective
administration  of the Fund as are not  provided by  employees  or other  agents
engaged by the Fund; provided, that the Adviser shall not have any obligation

<PAGE>


to  provide  under  this  Agreement  any  direct or  indirect  services  to Fund
shareholders,  any services related to the  distribution of Fund shares,  or any
other  services  which are the subject of a separate  agreement  or  arrangement
between  the  Fund and the  Adviser.  Subject  to the  foregoing,  in  providing
administrative services hereunder, the Adviser shall:

     1.2.1 Office Space,  Equipment and Facilities.  Furnish without cost to the
Fund,  or pay the cost of,  such  office  space,  office  equipment  and  office
facilities as are adequate for the Fund's need.

     1.2.2 Personnel.  Provide,  without  remuneration from or other cost to the
Fund,  the  services  of  individuals  competent  to  perform  all of the Fund's
executive,  administrative  and clerical  functions  which are not  performed by
employees or other agents  engaged by the Fund or by the Adviser  acting in some
other capacity pursuant to a separate agreement or arrangement with the Fund.

     1.2.3 Agents.  Assist the Fund in selecting and coordinating the activities
of the other  agents  engaged  by the Fund,  including  the  Fund's  shareholder
servicing agent, custodian, underwriter, administrator, independent auditors and
legal counsel.

     1.2.4 Directors and Officers. Authorize and permit the Adviser's directors,
officers and  employees who may be elected or appointed as Directors or officers
of the Fund to serve in such capacities, without remuneration from or other cost
to the Fund.

     1.2.5 Books and Records.  Assure that all  financial,  accounting and other
records  required to be maintained  and preserved by the Fund are maintained and
preserved  by it or on  its  behalf  in  accordance  with  applicable  laws  and
regulations.

     1.2.6 Reports and Filings.  Assist in the  preparation of (but not pay for)
all periodic reports by the Fund to its shareholders and all reports and filings
required to maintain the  registration  and  qualification  of the Fund and Fund
shares, or to meet other regulatory or tax requirements  applicable to the Fund,
under federal and state securities and tax laws.

2. Expenses of the Fund.

     2.1  Expenses to be Paid by Adviser.  The Adviser  shall pay all  salaries,
expenses and fees of the  officers,  Directors and employees of the Fund who are
officers, directors or employees of the Adviser.

     In the event that the Adviser  pays or assumes any expenses of the Fund not
required to be paid or assumed by the Adviser under this Agreement,  the Adviser
shall not be obligated  hereby to pay or assume the same or any similar  expense
in the  future;  provided,  that  nothing  herein  contained  shall be deemed to
relieve the Adviser of any  obligation to the Fund under any separate  agreement
or arrangement between the parties.

     2.2  Expenses to be Paid by the Fund.  The Fund shall bear all  expenses of
its  operation,  except those  specifically  allocated to the Adviser under this
Agreement  or under any  separate  agreement  between the Fund and the  Adviser.
Subject  to any  separate  agreement  or  arrangement  between  the Fund and the
Adviser,  the expenses  hereby  allocated  to the Fund,  and not to the Adviser,
include but are not limited to:

     2.2.1 Custody.  All charges of depositories,  custodians,  and other agents
for the transfer, receipt,  safekeeping,  and servicing of its cash, securities,
and other property.

     2.2.2  Shareholder  Servicing.  All expenses of  maintaining  and servicing
shareholder  accounts,  including,  but  not  limited  to,  the  charges  of any
shareholder servicing agent, dividend disbursing agent or other agent engaged by
the Fund to service shareholder accounts.


                                       2
<PAGE>


     2.2.3  Shareholder  Reports.  All expenses of  preparing,  setting in type,
printing and distributing reports and other communications to shareholders.

     2.2.4 Pricing and Portfolio Valuation. All expenses of computing the Fund's
net asset value per share,  including any equipment or services obtained for the
purpose of pricing shares or valuing the Fund's investment portfolio.

     2.2.5  Communications.  All charges  for  equipment  or  services  used for
communications  between the Adviser or the Fund and any  custodian,  shareholder
servicing agent,  portfolio accounting services agent, or other agent engaged by
the Fund.

     2.2.6 Legal and  Accounting  Fees. All charges for services and expenses of
the Fund's legal counsel and independent accountants.

     2.2.7  Directors'  Fees and Expenses.  All  compensation of Directors other
than those affiliated with the Adviser, all expenses incurred in connection with
such unaffiliated  Directors'  services as Directors,  and all other expenses of
meetings of the Directors and committees of the Directors.

     2.2.8 Shareholder Meetings.  All expenses incidental to holding meetings of
shareholders,  including the printing of notices and proxy materials,  and proxy
solicitations therefor.

     2.2.9 Federal  Registration  Fees. All fees and expenses of registering and
maintaining the  registration of the Fund under the Act and the  registration of
the Fund's shares under the Securities  Act of 1933 (the "1933 Act"),  including
all fees and expenses  incurred in connection with the  preparation,  setting in
type,  printing,  and  filing  of any  Registration  Statement,  Prospectus  and
Statement  of  Additional  Information  under  the 1933 Act or the Act,  and any
amendments or supplements that may be made from time to time.

     2.2.10 State  Registration  Fees. All fees and expenses of taking  required
action to permit the offer and sale of the Fund's shares under  securities  laws
of various states or jurisdictions, and of registration and qualification of the
Fund  under all other laws  applicable  to the Fund or its  business  activities
(including  registering the Fund as a broker-dealer,  or any officer of the Fund
or any person as agent or salesperson of the Fund in any state).

     2.2.11  Confirmations.  All expenses  incurred in connection with the issue
and  repurchase of Fund shares,  including the expenses of confirming  all share
transactions.

     2.2.12 Bonding and Insurance.  All expenses of bond,  liability,  and other
insurance  coverage  required by law or  regulation  or deemed  advisable by the
Directors of the Fund, including,  without limitation,  such bond, liability and
other insurance  expenses that may from time to time be allocated to the Fund in
a manner approved by its Directors.

     2.2.13 Brokerage  Commissions.  All brokers'  commissions and other charges
incident to the purchase, sale or lending of the Fund's portfolio securities.

     2.2.14 Taxes. All taxes or governmental  fees payable by or with respect to
the Fund to federal, state or other governmental agencies,  domestic or foreign,
including stamp or other transfer taxes.

     2.2.15 Trade  Association  Fees. All fees, dues and other expenses incurred
in  connection  with the Fund's  membership  in any trade  association  or other
investment organization.

     2.2.16  Nonrecurring  and  Extraordinary  Expenses.  Such  nonrecurring and
extraordinary  expenses as may arise  including the costs of actions,  suits, or
proceedings  to which the Fund is a party and the expenses the Fund may incur as
a result of its legal  obligation  to provide  indemnification  to its officers,
Directors and agents.


                                       3
<PAGE>


3. Advisory Fee.

     3.1 Fee. As compensation for all services rendered, facilities provided and
expenses paid or assumed by the Adviser under this Agreement, the Fund shall pay
the  Adviser  on  the  last  day of  each  month,  or as  promptly  as  possible
thereafter,  a management  fee at an annual rate of 1.75% of the Fund's  average
daily net assets.

4. Records.

     4.1 Tax  Treatment.  The Adviser shall  maintain,  or arrange for others to
maintain,  the books and  records of the Fund in such a manner  that  treats the
Fund as a separate entity for federal income tax purposes.

     4.2 Ownership.  All records  required to be maintained and preserved by the
Fund pursuant to the  provisions or rules or  regulations  of the Securities and
Exchange  Commission under Section 31(a) of the Act and maintained and preserved
by the  Adviser on behalf of the Fund are the  property of the Fund and shall be
surrendered by the Adviser promptly on request by the Fund;  provided,  that the
Adviser may at its own expense make and retain copies of any such records.

5. Reports to Adviser.

     The Fund shall  furnish or  otherwise  make  available  to the Adviser such
copies of the Fund's Prospectus, Statement of Additional Information,  financial
statements,  proxy  statements,  reports and other  information  relating to its
business  and  affairs  as the  Adviser  may,  at any time or from time to time,
reasonably require in order to discharge its obligations under this Agreement.

6. Reports to the Fund.

     The Adviser shall prepare and furnish to the Fund such reports, statistical
data and other  information  in such form and at such  intervals as the Fund may
reasonably request.

7. Services to Other Clients.

     Nothing  herein  contained  shall  limit the  freedom of the Adviser or any
affiliated   person  of  the  Adviser  to  render   investment   management  and
administrative  services to other  investment  companies,  to act as  investment
adviser or investment counselor to other persons,  firms or corporations,  or to
engage in other business activities.

8. Limitation of Liability of Adviser and its Personnel.

     Neither the Adviser  nor any  director,  officer of employee of the Adviser
performing  services for the Fund at the  direction or request of the Adviser in
connection with the Adviser's  discharge of its  obligations  hereunder shall be
liable for any error of judgment  or mistake of law or for any loss  suffered by
the Fund in connection with any matter to which this Agreement relates,  and the
Adviser shall not be responsible  for any action of the Directors of the Fund in
following or declining to follow any advice or  recommendation of the Adviser or
any sub-adviser retained by the Adviser pursuant to Section 7 of this Agreement;
provided,  that nothing herein  contained  shall be construed (i) to protect the
Adviser  against  any  liability  to the Fund or its  shareholders  to which the
Adviser would otherwise be subject by reason of willful misfeasance,  bad faith,
or gross negligence in the performance of the Adviser's  duties, or by reason of
the  Adviser's  reckless  disregard  of its  obligations  and duties  under this
Agreement,  or (ii) to protect any director,  officer or employee of the Adviser
who is or was a Director  or officer of the Fund  against any  liability  of the
Fund or its  shareholders  to which such person  would  otherwise  be subject by
reason of willful misfeasance, bad faith, gross negligence or reckless disregard
of the duties involved in the conduct of such person's office with the Fund.


                                       4
<PAGE>


9. Effect of Agreement.

     Nothing herein contained shall be deemed to require to the Fund to take any
action contrary to its Articles of Incorporation or its Bylaws or any applicable
law,  regulation or order to which it is subject or by which it is bound,  or to
relieve or deprive the  Directors  of the Fund of their  responsibility  for and
control of the conduct of the business and affairs of the Fund.

10. Term of Agreement.

     The term of this Agreement shall begin on the date first above written, and
unless sooner terminated as hereinafter provided, this Agreement shall remain in
effect  for a period of two years from the date of this  Agreement.  Thereafter,
this  Agreement  shall  continue  in effect  from year to year,  subject  to the
termination provisions and all other terms and conditions hereof; provided, such
continuance  is approved at least  annually by vote of the holders of a majority
of the  outstanding  voting  securities  of the Fund or by the  Directors of the
Fund; provided,  that in either event such continuance is also approved annually
by the vote,  cast in person at a meeting  called  for the  purpose of voting on
such approval, of a majority of the Directors of the Fund who are not parties to
this Agreement or interested  persons of either party hereto.  The Adviser shall
furnish  to the  Fund,  promptly  upon  its  request,  such  information  as may
reasonably  be  necessary  to  evaluate  the  terms  of  this  Agreement  or any
extension, renewal or amendment thereof.

11. Amendment or Assignment of Agreement.

     Any amendment to this  Agreement  shall be in writing signed by the parties
hereto;  provided,  that no such amendment shall be effective unless  authorized
(i) by resolution  of the  Directors of the Fund,  including the vote or written
consent of a majority of the  Directors  of the Fund who are not parties to this
Agreement or interested  persons of either party  hereto,  and (ii) by vote of a
majority of the outstanding  voting securities of the Fund. This Agreement shall
terminate automatically and immediately in the event of its assignment.

12. Termination of Agreement.

     This Agreement may be terminated as to the Fund at any time by either party
hereto,  without the payment of any penalty, upon sixty (60) days' prior written
notice to the other party;  provided,  that in the case of termination as to the
Fund,  such action shall have been  authorized  (i) by  resolution of the Fund's
Board of Directors,  including  the vote or written  consent of Directors of the
Fund who are not parties to this Agreement or interested persons of either party
hereto, or (ii) by vote of majority of the outstanding  voting securities of the
Fund.

13. Use of Name.

     The Fund is named the Orbitex Life Sciences & Biotechnology  Fund, Inc. and
the Fund may be identified,  in part, by the name  "Orbitex." The Adviser hereby
grants to the Fund a nonexclusive  right and license to use the Orbitex name and
as part of the  name  of the  Fund  only  for so long as this  Agreement  or any
extension,  renewal or amendment hereof remains in effect, including any similar
agreement  with any  organization  which shall have  succeeded to the  Adviser's
business as adviser or any  extension,  renewal or amendment  thereof  remain in
effect. The Fund agrees that it shall acquire no interest in the name "Orbitex,"
that all uses  thereof by the Fund shall inure to the benefit of the Adviser and
that is shall not challenge the validity or Adviser's ownership thereof.

14. This Agreement  shall be governed and construed in accordance  with the laws
of the State of New York.


                                       5
<PAGE>


15. Interpretation and Definition of Terms.

     Any question of  interpretation  of any term or provision of this Agreement
having a counterpart in or otherwise derived from a term or provision of the Act
shall be  resolved  by  reference  to such term or  provision  of the Act and to
interpretation  thereof, if any, by the United States courts, or, in the absence
of any controlling  decision of any such court, by rules,  regulations or orders
of the Securities and Exchange  Commission  validly issued  pursuant to the Act.
Specifically,   the  terms  "vote  of  a  majority  of  the  outstanding  voting
securities," "interested persons," "assignment" and "affiliated person," as used
in this  Agreement  shall have the meanings  assigned to them by Section 2(a) of
the Act. In addition,  when the effect of a requirement  of the Act reflected in
any provision of this  Agreement is modified,  interpreted or relaxed by a rule,
regulation  or order of the  Securities  and  Exchange  Commission,  whether  of
special or of general application, such provision shall be deemed to incorporate
the effect of such rule, regulation or order.

16. Captions.

     The captions in this  Agreement are included for  convenience  of reference
only and in no way define or delineate any of the provisions hereof or otherwise
affect their construction or effect.

17. Execution in Counterparts.

     This  Agreement may be executed  simultaneously  in  counterparts,  each of
which shall be deemed an original,  but both of which together shall  constitute
one and the same instrument.

     IN WITNESS WHEREOF,  the parties have caused this Agreement to be signed by
their  respective  officers  thereunto  duly  authorized as of the date and year
first above written.




                          ORBITEX LIFE SCIENCES & BIOTECHNOLOGY
                              FUND, INC.

                          By:
                             -----------------------------------


                            ORBITEX MANAGEMENT, INC.


                          By:
                             -----------------------------------


                                       6



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission